Skip to main content

JANE STREET GROUP, LLC

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in KYTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$899,366
-$812,307 QoQ
Shares Held
104,214
-42.8% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Derivatives in KYTX

reported options exposure · as of Mar 31, 2026
CallValue
$133,765
CallShares
15,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,248,975,671 across 317 Biotechnology names. KYTX ranks #125 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KYTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $899,366 104,214
2026-03-31 $133,765 15,500
2025-12-31 $1,711,673 182,093
2025-12-31 $124,080 13,200
2025-12-31 $515,120 54,800
2025-09-30 $1,193,106 198,851
2025-09-30 $90,000 15,000
2025-06-30 $269,449 87,769
2024-09-30 $191,652 39,193
2024-06-30 $164,835 21,978
2024-03-31 $920,098 37,041